Ad hoc notifications

You find our ad hoc notifications pursuant to Article 17 of the EU Market Abuse Regulation (Regulation (EU) No 596/2014) below.

Prior to July 3, 2016, ad hoc notifications were published pursuant to Section 15 of the German Securities Trading Act (Wertpapierhandelsgesetz).

11/21/23

Fresenius Medical Care AG & Co. KGaA: Favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised

11/1/23

Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care AG & Co. KGaA raises outlook for operating income in fiscal year 2023

2/21/23

Fresenius Medical Care AG & Co. KGaA initiates firm plans for change of the legal form into a German stock corporation

2/9/23

Fresenius Medical Care AG & Co. KGaA confirms review of the deconsolidation and a potential change of the legal form into a German stock corporation

12/5/22

Fresenius Medical Care AG & Co. KGaA: Ms. Helen Giza appointed as new CEO of the Management Board; Dr. Carla Kriwet agreed to resign as CEO and member of the Management Board

1 2 3 4

Contact us for further information

+49 6172 609 2525

Contact Investor Relations